Transcranial Doppler for Early Prediction of Cognitive Impairment after Aneurysmal Subarachnoid Hemorrhage and the Associated Clinical Biomarkers.

Published in: Stroke research and treatment (2020)

Cognitive impairment after the 3-month follow-up phase in aSAH patients was 22.5%. Acute hydrocephalus and DCI are highly associated with poor cognitive function in aSAH. Increased MFV is a strong predictor for poor cognitive function in aSAH. This trial is registered with NCT04329208.

Keyphrases

cognitive impairment
end stage renal disease
newly diagnosed
chronic kidney disease
ejection fraction
clinical trial
liver failure
prognostic factors
peritoneal dialysis
study protocol
patient reported outcomes
intensive care unit
phase iii
drug induced
phase ii
blood flow